NIH-funded research Sbir 2 grant

A wearable device to monitor breathing and prevent opioid-related breathing problems.

Official title: Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression

Funded at Rtm Vital Signs, LLC · NIH-11146916 · Data updated 2026-11-12

This study is testing a new wearable device that helps keep an eye on your breathing and oxygen levels if you're using opioids, so it can alert you and your doctors if there's a risk of breathing problems, making it safer for patients in the hospital.

More Depression research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionRtm Vital Signs, LLC
NIH-funded
Lab location1 site (Philadelphia, UNITED STATES)
Project startSeptember 15, 2023
Project endNovember 30, 2026
Funding year2025
Award (this year)$1,276,940
NIH project number4R44DA059491-02
Project IDNIH-11146916 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include hospitalized patients who are being treated with opioids and are at risk for respiratory depression.

Less likely to help

Patients who are not using opioids or those who are not hospitalized may not benefit from this research.

What this research studies

This research focuses on developing a wearable, wireless respiratory monitoring system designed to detect and predict opioid-induced respiratory depression (OIRD). The device uses an acoustic sensor to continuously measure various respiratory parameters, including breathing rate and oxygen levels, and calculates a Risk Index Score every 20 seconds. By providing real-time alerts, the system aims to prevent severe respiratory issues and improve patient safety, particularly for those receiving opioid medications in hospitals. The technology has received FDA Breakthrough Device Designation, highlighting its potential to address a critical healthcare need.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of opioid-related respiratory depression and improve patient outcomes in hospitals.

How similar studies have gone: Other research has shown promise in developing wearable monitoring technologies for respiratory issues, but this specific approach targeting opioid-induced respiratory depression is novel.

Where this research is happening

  • Rtm Vital Signs, LLC
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Dicciani, Nance Katherine — Rtm Vital Signs, LLC
  • Study coordinator: Dicciani, Nance Katherine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.